Author

Katarina Halpin-Veszeleiova

Northeastern UniversityORCID 0009-0009-0121-555XUnclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cancer & tumor microenvironment· 2 Organism:mouse· 2 Research Focus:cell signaling & trafficking· 1 Research Focus:cell type annotation· 1 Research Focus:development & morphogenesis· 1 Approach:experimental assay· 1 Approach:genetic perturbation / CRISPR· 1

Frequent Co-Authors

Alex SmashnoviD· 1 shared Anne E. DodsoniD· 1 shared Ashish YeriiD· 1 shared Ashley C Apro· 1 shared Bashar M. Hamza· 1 shared Bruce D. SpiessiD· 1 shared Camille Bahr· 1 shared Caroline P. Bullock· 1 shared

Activity by Year

2025-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 24 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperImmunology

Alex SmashnovORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

ImmunologybioRxivPreprintJan 23, 2026

Dual-inactivation of Regnase-1 and SOCS1 rewires exhausted CD8+ T cell fate to enhance anti-tumor functionality

Isabelle Le Mercier, David Monteiro, Katarina Halpin-Veszeleiova…·Micah J. Benson

This study identifies Regnase-1 and SOCS1 dual-inactivation as a strategy to enhance anti-tumor functionality of CD8+ T cells by rewiring their differentiation and effector state.

2 citations

mousegenetic perturbation / CRISPR

𝕏 PostBluesky

ImmunologyJCI InsightPeer-reviewedMar 23, 2025

Oxygen carrying nanoemulsions and respiratory hyperoxia eliminate tumor hypoxia-induced suppression and improve cancer immunotherapy

Katarina Halpin-Veszeleiova, Michael P. Mallouh, Lucy M. Williamson…·Stephen Matthew Hatfield

This study shows oxygen-carrying nanoemulsions and respiratory hyperoxia reduce tumor hypoxia, enhance T cell and NK cell infiltration, and improve cancer immunotherapy outcomes.

28 citationstop 2%

mouseexperimental assay

𝕏 PostBluesky